Position in ZLAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$885,424
+$532,200 QoQ
Shares Held
47,072
+249.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $285,597,237 across 374 Biotechnology names. ZLAB ranks #92 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
255,431 | $7,075,438 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,632 | $6,980,313 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
80,519 | $6,046,171 | |
| 4 | EXEL |
Exelixis, Inc.
|
134,413 | $5,764,973 | |
| 5 | NUVL |
Nuvalent, Inc.
|
53,354 | $5,466,117 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
160,880 | $5,442,570 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
93,609 | $5,287,972 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
59,502 | $5,174,888 |
All Filings in ZLAB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $885,424 | 47,072 | Shares | Defined | 2026-05-15 | |
| 2024-12-31 | $353,224 | 13,487 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $763,258 | 31,618 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $507,474 | 29,283 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $393,659 | 24,573 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $260,345 | 9,526 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $391,103 | 14,104 | Shares | Defined | 2023-08-14 | |
| 2021-09-30 | $526,844 | 4,999 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||